| |
| 1st Session: |
|
Dr. Yank D. Coble |
President, the World Medical Association Past
President of the American Medical Associotion |
|
"Cancer: a Global Disease" |
|
Professor Karol Sikora |
Imperial College School of Medicine, UK |
|
"A UK Perspective" |
| |
|
| 2nd Session: |
|
Dr. Douglas R. Lowy |
National Cancer Institute/NIH, USA |
|
"HPV Virus-like Particles
and Vaccine Development" |
|
Professor Pefer L. Stern |
Paterson Institute, Manchester, UK |
|
"Therapeutic HPV vaccines" |
|
Professor Alan Rickinson |
The University of Birmingham, UK |
|
"Vaccines Targeting EB
Positive Malignancies" |
| |
|
| 3rd Session: |
|
Dr. Jeffrey Schlom |
National Cancer lnstitutee/NIH, USA |
|
"Critical Issues in the
Development of Cancer vaccines" |
|
Dr. Olivera J. Finn |
University of Pittsburgh, USA |
|
"Overcoming
the Tumour Challenge fo Cancer Vaccines by Focusing on Premalignant
Disease" |
|
Dr. Christian Ottensmeier |
University of Southampton, UK |
|
"DNA Vaccines" |
|
Professor Martin Glennie |
University of Southampton, UK |
|
"Immunostimulatory
Antibodies" |
|
Professor Angus Dalgleish |
St George's Hospital Medical School |
|
"The Role
of Allogeneic Cells and Dendritic Cell Antigen Presentation
in the Development of Effective Cancer Vaccines" |
| |
|
| 4th Session: |
|
Dr. Lowell T. Harmison,
Dr. Douglas Lowy,
Dr. Jeffrey Schlom,
Dr. Jeffrey Weber |
|
|
"The U.S. Perspective" |
|
Dr. Brian Davies |
Clinical Trials Consultant, MHRA |
|
"The UK Perspective" |
|
Dr. Jean-Ybes Bonnefoy,Direcfor |
Concerople Lyon Rhone-Alpes, France |
|
"The French Perspective" |
|
Professor Andrei Kozlov |
St. Petersburg University, Russia |
|
"The Russian Perspective" |
| |
|
| 5th Session: |
|
Dr. Ralph M. Steinman |
Rockefeller University, USA |
|
"Dendritic Cells as Targets
for Immunotherapy" |
 |
|
|
Professor Gerold Schuler |
University of Erlagen, Germany |
|
"Dendritic Cell-Based
Vaccination Against Cancer" |
|
Dr. Jacques Banchereau |
Baylor Institute for Immunology Research, USA |
|
"Dendritic Cell Vaccines
in Melanoma" |
|
Dr. James J. Mule |
Moffitt Cancer Centre, USA |
|
"Experimental Strategies
to Enhance the Potency of Dendritic Cell-Based Cancer Vaccines
for Clinical Use" |
|
Professor Laurence Young |
The University of Birmingham |
|
"Arming Dendritic Cells
for Cancer Immunotherapy" |
|
Professor Georg Stingl |
University of Vienna Medical School, Austria |
|
"Immunostimulation via
the Skin - A Means of cancer Immunotherapy" |
| |
|
| 6th Session: |
|
Dr. Richard Vile |
Mayo Clinic, USA |
|
"Exploiting the Intentional
Induction of Autoimmune Reactivity to Treat Metastatic Disease" |
|
Professor Robert E. Hawkins |
University of Manchester, UK |
|
"Clinical Evaluation of
5T4 as a Novel Target for Cancer Immunotherapy" |
|
Professor Vincenzo Cerundolo |
University of Oxford, UK |
|
"Immunodominance: "Lessons
from Clinical Trials in Melanoma Patients"" |
| |
|
| 7th Session: |
|
Dr. Dean L. Mann |
University of Maryland, USA |
|
"Infusion of Anfi-CD3/Anti-CD28
Expanded T-cells Post-Stem Cell Transplant Alters an Immune
Response to a Pre-Transplant vaccine: Investigation of the Possible
Role of Cytokines/Chemokines in this Response" |
|
Dr. Cornelis J.M. Melief |
University Hospital Leiden, the Netherlands |
|
"Precision Guiding of
Cytolytic T-Lymphocyte Responses" |
|
Dr. Jeffrey Weber,Norris
Comprehensive Cancer Center |
University of Southern California, USA |
|
"New Paradigms in Antigen
Specific Approaches to Melanoma" |
| |
|
| 8th Session: |
|
Professor Hans Wigzell |
Karolinska lnstitutet, Sweden |
|
"Summary Talk" |
